Paul Tudor Jones's MPLT Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 36,740 shares of MapLight Therapeutics, Inc. (MPLT) worth $746,924, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in MPLT, representing a fresh investment thesis on this company. Largest reduction occurred in Q1 2026, reducing 11,100 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's MapLight Therapeutics (MPLT) Holding Value Over Time
Track share changes against reported price movement
Quarterly MapLight Therapeutics (MPLT) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -11,100 | Reduce 23.20% | 36,740 | $20.33 |
| Q4 2025 | +47,840 | New Buy | 47,840 | $17.57 |
Paul Tudor Jones's MapLight Therapeutics Investment FAQs
Paul Tudor Jones first purchased MapLight Therapeutics, Inc. (MPLT) in Q4 2025, acquiring 47,840 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held MapLight Therapeutics, Inc. (MPLT) for 2 quarters since Q4 2025.
Paul Tudor Jones's largest addition to MapLight Therapeutics, Inc. (MPLT) was in Q4 2025, adding 47,840 shares worth $840,310.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 36,740 shares of MapLight Therapeutics, Inc. (MPLT), valued at approximately $746,924.
As of the Q1 2026 filing, MapLight Therapeutics, Inc. (MPLT) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in MapLight Therapeutics, Inc. (MPLT) was 47,840 shares, as reported at the end of Q4 2025.